Adipokines are present in inflammatory processes and may be directly related to periodontal disease. Moreover, their activities may be regulated by fatty acids. The goal of this study was to quantify the concentrations of the main adipokines, leptin, adiponectin and resistin, and the docosahexaenoic (DHA), docosapentaenoic (DPA), eicosapentaenoic (EPA) and arachidonic (AA) fatty acids, in patients with generalized chronic periodontitis. As a secondary objective, the ratios of these substances in the blood of these patients were evaluated. The study included 15 systemically healthy patients with generalized chronic periodontitis (test group) and 15 patients with gingivitis (control group). Medical and periodontal parameters and blood samples were collected. Serum concentrations of fatty acids were analyzed by gas chromatography and adipokines by multiplex bead immunoassay. There was no significant difference in adipokines between groups. However, there was a tendency for lower values of adiponectin in periodontitis patients. Regarding the fatty acids, they were significantly higher in the test group compared with controls. The res/DHA, res/AA, adipon/DHA, adipon/AA and adipon/DPA ratios were significantly lower in the test group. There was no significant correlation between adipokines and clinical parameters and between adipokines and fatty acids levels. It was concluded that generalized chronic periodontitis patients showed significantly higher levels of fatty acids in comparison to gingivitis; adiponectin revealed a trend to lower values in the periodontitis group, even after Ancova correction. The ratios suggest a minor proportion of adiponectin and resistin in relation to the fatty acids in patients with generalized chronic periodontitis.
Introduction
The term periodontal disease refers to inflammatory disorders induced by pathogenic microorganisms of the biofilm formed surrounding the teeth. Gingivitis, the mildest form of periodontal disease, is highly prevalent and readily reversible by effective oral hygiene. Inflammation extending deep into the tissues causing loss of connective tissue and alveolar bone is known as periodontitis. It results in the formation of pockets between the gingival tissue and tooth root, and may result in tooth loss (1) .
Although bacteria are necessary for development of periodontal disease, it also requires a susceptible host. The host response is traditionally mediated by lymphocytes T and B, neutrophils and monocytes/macrophages. They are triggered to produce inflammatory mediators, including cytokines, chemokines, arachidonic acid metabolites and proteolytic enzymes, which collectively contribute to tissue degradation and bone resorption by activation of various degradation pathways (2) .
These immune cells, their products (especially cytokines) and their complex interactions have led to studies focused on components of the immune-inflammatory response (3) . Recently, it was demonstrated that adipokines derived from adipose tissue, are important in various physiological and pathological inflammatory responses (4) . Adipose tissue is no longer considered an inert tissue that functions only as an energy carrier; it is recognized as an endocrine/paracrine organ, which is able to regulate various physiological processes. Over 50 adipokines secreted by adipose tissue have been described, including hormones, cytokines, chemokines and other proteins with specific biological functions. Leptin, adiponectin and resistin are the most studied adipokines (5, 6) . Initially considered as markers of weight regulation and insulin resistance, it is becoming clear that these adipokines are involved in a variety of functions and conditions including cardiovascular disease, diabetes, and inflammatory diseases (5) . Altered levels of adipokines have been observed in systemic inflammatory conditions such as inflammatory bowel disease and rheumatoid arthritis, but little is known about the potential association between adipokines and chronic periodontitis in systemically healthy individuals (4, 6, 7) .
Polyunsaturated fatty acids omega-3 and -6 (PUFAs n-3 and n-6) also participate in chronic inflammation and may act as important inflammatory modulators. The reason for this effect is unknown, but an increased expression of cyclooxygenase (COX) and lipoxygenase (LOX) can affect the production of some eicosanoids, lipoxins, resolvins and other oxidized derivatives (8) . The most important PUFAs are derivatives of n-3: docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and docosapentaenoic (DPA) acid, and of n-6: arachidonic acid (AA).
Fatty acids may influence the expression of adipokines such as leptin, resistin and adiponectin directly by interaction with transcription factors, or indirectly by unknown mechanisms, possibly linked to oxidation, synthesis or storage of fatty acids. Since fatty acids are the major components of adipose tissue, is of paramount importance to clarify the biological effects of their different types in the expression of adipokines (9) . Therefore, the aim of this study was to compare the concentrations of leptin, resistin and adiponectin and DHA, DPA, EPA and AA in the blood of patients with generalized chronic periodontitis and of patients with gingivitis. A secondary objective was to evaluate the proportion of these substances in the serum of these patients.
Material and Methods
Fifteen patients with generalized chronic periodontitis (3 men and 12 women, mean age: 45.7±9.4 years) and 15 patients with gingivitis (3 men and 12 women, mean age 32.1±7.8 years) participated in the study. All subjects were seeking for dental treatment at the Rio de Janeiro State University (UERJ), Rio de Janeiro, RJ, Brazil. The study protocol was approved by the Ethics Committee of the University Hospital Pedro Ernesto (UERJ, Rio de Janeiro, Brazil -2714/2010). Patients had at least 20 natural teeth and were diagnosed according to American Academy of Periodontology criteria (10) .
Participants reported no present systemic disease and were not taking any medication that could affect periodontal conditions. They were non-smokers and neither used antibiotics for a minimum period of the last six months nor anti-inflammatory for the last three months. Participants did not have periodontal treatment in the last six months. Women were included if they were not pregnant or lactating. All subjects signed an informed consent form before inclusion in the study.
Demographic and Clinical Measures
Anamnesis was performed and age, sex, race, smoking habit, body mass index (BMI), presence of systemic diseases, and use of medications were collected. Race was classified as white or non-white. BMI was measured as the weight (kg) divided by the height squared (m 2 ).
The measured clinical periodontal parameters were: percentage of sites that bled on probing (BOP), plaque index (PI), probing depth (PD) and clinical attachment level (CAL). PD and CAL were measured at six sites per tooth (mesio-buccal, buccal, disto-buccal, mesio-lingual, lingual and disto-lingual), except for third molars. A computerized periodontal probe (Probe Florida, Gainesville, FL, USA) was used together with silicon plates (1.0 mm). Blood pressure was measured using an automatic pressure device (Omron Healthcare, São Paulo, SP, Brazil). Two previously calibrated examiners performed the examinations. Intrarater agreement was 90% and inter was 70% for PD and CAL variables, accepting 1 mm more or less.
Food Frequency Questionnaire
A food frequency questionnaire (FFQ) was applied by a nutritionist in a personal interview. The questionnaire was developed to record the habitual food intake by adults, including questions about 30 items grouped according to the Brazilian standard meal. The items in the FFQ included an extensive list of specific fish and shellfish, as well as walnuts, flaxseed, flaxseed oil, cod liver oil and canola oil. For each item, the categories ranged from never to the number of times each month, each week or each day that were ingested. The purpose of this questionnaire was to eliminate patients who were taking any nutritional supplement or were taking large quantities of n-3. From this FFQ, it was found that no patient was having supplementation with n-3.
Blood Collection
Subjects were instructed not to eat for 12 h prior to blood collection, which was performed at the University Hospital Pedro Ernesto. Blood samples (20 mL) were taken in the morning (8 o'clock) by venous puncture and placed in tubes containing an anticoagulant or not. A total of 4 mL was transferred to a glass tube (BD Vacutainer, Franklin Lakes, NJ, USA) containing 7.2 mg K 2 EDTA for analysis of glycated hemoglobin and blood count. Another 4 mL were transferred to glass tubes (BD Vacutainer) with 6 mg of NaF and 12 mg Na 2 EDTA for glucose analysis. A total of 8 mL was transferred to glass tubes with clot activator to analyze the lipid profile, ultrasensitive C-reactive protein (PCRhs), insulin, PUFAs n-3 and n-6 (EPA, DHA, DPA and AA) and adipokines (adiponectin, resistin and leptin). All samples were immediately centrifuged for 5 min, except the K 2 EDTA, and used for immediate analysis or stored at -70 °C for further analysis. Laboratory tests were also conducted at the University Hospital Pedro Ernesto. Plasma glucose, triglycerides, total cholesterol, high density lipoprotein (HDL-C), lowdensity cholesterol (LDL-C), cholesterol in very low density lipoprotein (VLDL-C), glycated hemoglobin, insulin and leukocyte counts were measured using routine automatic analyzer (DLE, Laboratory Medicine, Rio de Janeiro, RJ, Brazil). PCRhs was determined using a highly sensitive immunoturbidimetric method (DiaSys Diagnostic Systems, Holzheim, Germany). PUFAs were analyzed in serum after extraction of lipids, with rust prevented by the addition of butylated hydroxytoluene. The organic phase containing total lipids was dried under nitrogen flow and the residue was methylated (11) . Serum fatty acids were extracted and analyzed by gas chromatography. The identification and quantification of peaks in gas chromatography of fatty acid methyl esters were made using a commercial standard (Supelco, Bellefonte, PA, USA).
Adipokine levels were determined using an immunoassay with multiplex bead. Fifty microliters of blood samples were analyzed for adiponectin and resistin using a commercially available (1H-HADK1MAAG) kit, as well as leptin (HADK1MAAG-2K) on a Luminex analyzer (Luminex; MiraiBio, Alameda, CA, USA) according to the manufacturer's instructions. Briefly, 96-well filter were pre-moistened with washing buffer and the solution was aspirated from the wells using a vacuum suction (Millipore Corporation, Billerica, MA, USA). Microspheres coated with monoclonal antibodies against three different analyzed targets were added to the wells. Samples and standards were pipetted into the wells and incubated overnight at 4 °C. The wells were aspirated and washed, and a mixture of secondary biotinylated antibody was added. After incubation for 1 h, streptavidin-conjugated fluorescent protein, R-phycoerythrin (streptavidin-RPE) was added to the beads and incubated for 30 min. After washing to remove non-adherent reagent, buffer solution sheath fluid (Luminex, MiraiBio) was added to the wells with the beads (up to 100 per analysis) to be analyzed in the analyzer microspheres (Luminex 100™; Luminex, MiraiBio). The concentrations of the unknown samples (antigens in blood samples) were calculated from the standard curve using the Bio-Plex Manager Software (Bio-Rad Laboratories, Hercules, CA, USA). The levels of adipokines were expressed as total quantity.
Statistical Analysis
The calculation of sample size was estimated at 15 individuals in each group to have α=0.05 and power of 0.80, considering the mean and standard deviation of the variable DPA (12) . Kolmogorov-Smirnov test was performed to assess the normality of the data. Some variables were normal and others not, so nonparametric tests were chosen to use for almost all, with the data being presented as median and interquartile range; except for age, which was presented as mean and standard deviation. Then, to assess the significance of difference between groups, was used Fisher exact test for categorical variables, sex and race and for the other variables was used the Mann-Whitney test, significance was set at 5% (p≤0.05). Analysis of covariance (Ancova) was used to adjust for age. Correlation between fatty acids, adipokines and clinical parameters was performed with Spearman correlation test, and significance was determined at r≥0.5 and p≤0.01. Statistical analysis was performed using SPSS v.19.0 (IBM, Chicago, IL, USA).
Results

Demographic Data
Demographic data indicated that groups were similar for sex and race. Periodontitis group showed a higher mean age (p≤0.05 - Table 1 ). BMI median (interquartile range) in the test group was 28.8 (6.6).
Clinical Data
Periodontal parameters of both groups are shown in Table 2 . The percentages of sites with PD≤3 mm and CAL≤1 mm were significantly higher in patients with gingivitis compared to patients with periodontitis (p≤0.01). The percentage of sites with CAL 2-4 mm was significantly higher in patients with periodontitis compared to patients with gingivitis (p≤0.01). The percentage of positive sites for dental plaque was significantly higher in patients with periodontitis (p≤0.01). However, there was no difference in the percentage of BOP between groups (p>0.05).
PUFAs and Adipokines
There was no significant difference between the groups for resistin, adiponectin and leptin (p>0.05). However, there was a tendency for lower values of adiponectin in periodontitis patients, even after Ancova correction. Regarding DHA, DPA, EPA and AA, difference was significantly larger for the group of periodontitis patients compared to gingivitis group (p=0.029, p=0.004, p=0.16 and p=0.002, respectively) ( Table 3) .
The ratios between resistin and fatty acids were significantly higher in gingivitis group (res/EPA p=0.006; res/ DHA p=0.002; res/AA p=0.001; res/DPA p=0.001); as well as the ratios between adiponectin and fatty acids (adipon/EPA p=0.004; adipon/DHA p=0.017; adipon/AA p=0.007; adipon/DPA p=0.003). The ratios between leptin and fatty acids showed no statistically significant difference (Table 4 ).
Blood Parameters
Levels of triglycerides and glucose were higher in periodontitis patients (p=0.050 and p=0.019), while HDL levels were lower in patients with periodontitis (p=0.050). For all other evaluated parameters, there was no significant difference between groups.
Correlations
Correlations between PUFAs, adipokines and clinical parameters are shown in Table 5 . PD had a positive correlation with DHA (r=0.5, p=0.007), DPA (r=0.6, p=0.001) and AA (r=0.6; p=0.001). CAL had a positive correlation with DHA (r=0.5, p=0.010), DPA (r=0.5, p=0.003) and AA (r=0.6, p=0.001). PI had a positive correlation with DPA (r=0.5, p=0.008). BOP did not show significant correlations. Correlations between PUFAs and adipokines and among themselves are shown in Table  6 . None of the correlations was statistically significant.
Data Adjusted for Age (Ancova)
After adjusting for age, differences remained significantly higher for DPA and AA (p=0.048 and p=0.009, respectively) for the periodontitis group (Table 3 ). The medians of the ratios between adipokines and fatty acids remained significantly higher for res/ DHA and res/AA (p=0.018 and p=0.003, respectively); for adipon/DHA, adipon/AA and adipon/DPA (p=0.034, p=0.015 and p=0.016, respectively) for the gingivitis group (Table 4) . In blood parameters, differences were no longer significant for triglyceride, HDL and glucose and became significantly higher for insulin in periodontitis group (p≤0.001).
Discussion
In the present study, all fatty acids showed higher levels in periodontitis group, with significant difference for DPA and AA. In a previous study by the same group, Figueredo et al. (12) also found higher levels in periodontitis group, with significance for all fatty acids. Ramirez-Tortosa et al. (13) found higher levels of AA in patients with periodontitis. These results suggest that higher AA levels are implicated in pathogenesis of periodontitis. Regarding DHA, Ramirez-Tortosa et al. (13) found no significant difference when comparing patients with periodontitis and control. Requirand et al. (14) found lower levels in patients with bone loss. Such differences are difficult to explain, but may be related to intake of n-3. In the present study, the food frequency questionnaire was made in order to eliminate patients who used any type of supplementation or who ingested large amounts of n-3, and the obtained values are below those recommended by the World Health Organization (15); even so, differences between groups may have remained.
Serum adipokine levels between groups of patients with gingivitis and with periodontitis showed no significant difference. Furugen et al. (16) (16) classified periodontitis as the presence of at least one pocket≥6 mm. In the present study probably if the number of patients were increased, there could be statistical difference, since a tendency to lower values of resistin and adiponectin in the group with periodontitis was observed.
Regarding resistin, Devanoorkar et al. (7) (7) study. There were also differences in the degree of involvement and classification of periodontitis among studies. A limitation of the present study was that the body weight was not standardized in control group patients, which rules out the calculation of BMI. This did not allow to completely control the BMI effects on the results and thus, it might be a source of bias. Overweight and obesity may alter adipokines and fatty acids levels, due to increased inflammatory status. Leptin showed higher levels in periodontitis group, but did not reach statistical significance. Karthikeyan and Pradeep (17) and Shimada et al. (18) found significant differences in leptin levels, higher among subjects with periodontitis compared with those considered healthy, which is similar to the results of this study. Ay et al. (4) found no difference in serum levels between groups of patients who were divided into healthy, gingivitis, chronic and aggressive periodontitis. A possible explanation for this discrepancy in results is the involvement of factors that may have influenced the values of leptin, such as BMI. Karthikeyan and Pradeep (17) and Shimada et al. (18) used the normal range of BMI as a selection criterion. In addition to other factors, such as the inclusion of smokers, the degree of inflammation found in patients and classification of periodontitis, Ay et al. (4) included aggressive periodontitis; the other authors included only chronic periodontitis. There was no correlation in this study between levels of adipokines and periodontal parameters (PD, CAL, PI and BOP). On the other hand, Shimada et al. (18) found a positive correlation between leptin levels and the following clinical parameters: PD, CAL, bone loss and BMI, which sustain the inflammatory role of this adipokine. Furugen et al. (16) found a positive correlation between BOP and resistin, which indicates its presence in inflammation. They found a significant but weak negative correlation between adiponectin levels and CAL; this result the authors credited to the low levels of adiponectin observed in males with severe clinical attachment loss. Adiponectin also correlated negatively with leukocyte count, which indicates its role as an anti-inflammatory mediator.
It may be concluded that generalized chronic periodontitis presents significantly greater differences in levels of fatty acids when compared to gingivitis. Adiponectin showed a tendency to lower values in periodontitis group, even after Ancova correction. The results of the ratios suggested a lesser proportion of adiponectin and resistin in relation to the fatty acids in periodontitis.
Resumo
As adipocinas estão presentes em processos inflamatórios e podem estar diretamente relacionadas à doença periodontal. Além disso, suas atividades podem ser reguladas pelos ácidos graxos. Este estudo teve como objetivo quantificar as concentrações das principais adipocinas, leptina, adiponectina e resistina, e dos ácidos graxos: ácido docosahexaenóico (DHA), ácido docosapentaenóico (DPA), ácido eicosapentaenóico (EPA) e ácido araquidônico (AA), em pacientes com periodontite crônica generalizada. Como objetivo secundário, avaliar as proporções destas substâncias no sangue desses pacientes. O estudo incluiu 15 pacientes sistemicamente saudáveis com periodontite crônica generalizada (grupo teste) e 15 com gengivite (grupo controle). Foram coletados parâmetros médicos e periodontais e amostras de sangue. As concentrações séricas dos ácidos graxos foram analisadas por cromatografia gasosa e as das adipocinas foram analisadas pelo método multiensaio multiplex. Não houve diferença significativa entre os níveis de adipocinas entre os grupos. No entanto, houve uma tendência para menores valores nos níveis da adiponectina nos pacientes com periodontite. Com relação aos ácidos graxos, os valores foram significativamente maiores no grupo teste em comparação com os controles. As razões entre res/DHA, res/AA, adipon/DHA, adipon/AA e adipon/DPA foram significativamente menores no grupo teste. Não houve correlação significativa entre as adipocinas e os parâmetros clínicos e entre os níveis de adipocinas e ácidos graxos. Conclui-se que pacientes com periodontite crônica generalizada apresentaram níveis significativamente maiores de ácidos graxos em relação à gengivite, adiponectina apresentou uma tendência a valores menores no grupo periodontite, mesmo após a correção de Ancova. Os resultados das razões sugerem uma menor proporção de adiponectina e resistina em relação aos ácidos graxos em pacientes com periodontite crônica generalizada.
